References
- The Task Force for the Management of Arterial Hypertension of the European Society of hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. Eur Heart J. 2007;28:1462–1536.
- Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: Diagnosis, evaluation, and treatment. Hypertension. 2008;51:1403–1419.
- Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension durability of blood pressure reduction out to 24 months. Hypertension. 2011;57:911–917.
- Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. Lancet. 2010;376:1903–1909.
- Page IH, Heuer GJ. A surgical treatment of essential hypertension. J Clin Invest. 1935;14:22–26.
- Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009;361:932–934.
- Chapman N, Dobson J, Wilson S, Dahlöf B, Sever PS, Wedel H, et al. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension. 2007; 49:839–845.
- Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens. 2003;16:925–930.
- Ouzan J, Peraut C, Lincoff AM, Carré E, Mertes M. The role of spironolactone in the treatment of patients with refractory hypertension. Am J Hypertens. 2002;15:333–339.
- Vaclavik J, Sedlak R, Plachy M, Navrátil K, Plásek J, Jarkovsky J, et al. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): A randomized, double-blind, placebo-controlled trial. Hypertension. 2011;57:1069–1075.
- Satyapal KS, Haffejee AA, Singh B, Ramsaroop L, Robbs JV, Kalideen JM. Additional renal arteries: Incidence and morphometry. Surg Radiol Anat. 2001;23:33–38.
- Kem DC, Lyons DF, Wenzl J, Halverstadt D, Yu X. Renin-dependent hypertension caused by non focalstenotic aberrant renal arteries: Proof of a new syndrome. Hypertension. 2005;46:380–385.
- Marshall AG. Aberrant renal arteries and hypertension. Lancet. 1951;2:701–705.
- Gupta A, Tello R. Accessory renal arteries are not related to hypertension risk: A review of MR angiography data. Am J Roentgenol. 2004;182:1521–1524.